United Therapeutics Balance Sheet
UTHR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
United Therapeutics had $7.9B in total assets and $7.1B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.6B | $1.7B | $1.2B | $961.2M | $894.8M | $738.7M | $738.4M | $669.2M | $831.8M | $1.0B | $831.8M | $397.7M | $284.3M | $252.2M | $100.4M |
| Accounts Receivable | $350.2M | $279.3M | $278.9M | $220.4M | $198.7M | $157.4M | $151.4M | $175.7M | $297.1M | $214.5M | $192.8M | $162.3M | $126.3M | $116.6M | $88.7M |
| Inventory | $183.1M | $157.9M | $111.8M | $102.0M | $93.8M | $86.5M | $93.4M | $101.0M | $107.9M | $100.0M | $81.3M | $66.9M | $47.8M | $37.3M | $46.0M |
| Current Assets | $3.7B | $3.9B | $3.6B | $3.4B | $2.3B | $2.2B | $1.9B | $1.8B | $1.4B | $1.4B | $1.3B | $957.6M | $914.4M | $668.5M | $562.5M |
| PP&E (Net) | $1.7B | $1.2B | $1.0B | $861.5M | $780.9M | $731.6M | $738.5M | $699.7M | $489.3M | $489.3M | $495.8M | $478.4M | $464.9M | $366.0M | $306.0M |
| Goodwill | $32.3M | $32.3M | $33.7M | $28.0M | $28.0M | $28.0M | $28.0M | $31.5M | $13.7M | $10.3M | $10.3M | $10.3M | $10.7M | $10.5M | $8.1M |
| Total Assets | $7.9B | $7.4B | $7.2B | $6.0B | $5.2B | $4.6B | $3.9B | $3.4B | $2.9B | $2.3B | $2.2B | $1.9B | $2.1B | $1.6B | $1.5B |
| Current Liabilities | $560.6M | $738.1M | $804.4M | $343.2M | $305.4M | $323.3M | $463.0M | $276.6M | $444.7M | $332.5M | $440.7M | $504.3M | $687.7M | $176.8M | $212.6M |
| Shareholders' Equity | $7.1B | $6.4B | $6.0B | $4.8B | $4.0B | $3.4B | $2.8B | $2.8B | $1.6B | $1.9B | $1.6B | $1.2B | $1.3B | $883.9M | $653.0M |